Task: Answer the multiple-choice question.
Question: Which drug exhibits a -36.757% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1nonc1NC(=O)CSc1nc2ccccc2o1
(b) COCCN1CCN(C(=O)CCc2nnc(CCC3CCCCC3)o2)CC1
(c) O=C(CCC(=O)c1cccs1)c1cccs1
(d) C1=CC2c3ccccc3NC(c3ccncc3)C2C1
Answer: a. Cc1nonc1NC(=O)CSc1nc2ccccc2o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nonc1NC(=O)CSc1nc2ccccc2o1
Cc1nonc1NC(=O)CSc1nc2ccccc2o1
2-(1,3-benzoxazol-2-ylsulfanyl)-N-(4-methyl-1,2,5-oxadiazol-3-yl)acetamide